KIN News and Press, Kindred Biosciences Inc. From 08/31/20

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

Gainers:  Aimmune Therapeutics (NASDAQ: AIMT ) +171% . More news on: Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., Genworth Financial, Inc., Stocks on the move, Read more ...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 172 weeks of public selections as part of this ongoing live forward-testing resea...

Kindred Biosciences, Inc. (KIN) Q2 2020 Results Earnings Conference Call August 5, 2020, 4:30 PM ET Company Participants Richard Chin - Chief Executive Officer Wendy Wee - Chief Financial Officer Katja Buhrer - Vice President, Corporate Development and IR Conference Call Parti...

AnPac Bio-Medical Science (NASDAQ: ANPC ) +112% . on validating approved COVID-19 antibody test. More news on: AnPac Bio-Medical Science Co., Ltd., Huttig Building Products, Inc., Plus Therapeutics, Inc., , Read more ...

Kindred Biosciences (NASDAQ: KIN ) : Q2 GAAP EPS of $0.60 beats by $0.47 . More news on: Kindred Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SAN FRANCISCO , Aug. 5, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the second quarter ended June 30, 2020 and provided updates on its program...

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. "For the first time in ten years, we were unable to host our mid-year conference, which ...

SAN FRANCISCO , July 23, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will release its second quarter 2020 financial results on August 5, 2020 , after the market close. The Company will host a...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...